Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is a medium sized multinational pharmaceutical company based in Hyderabad, India. The company was founded by Dr Anji Reddy in 1984. Dr Reddy’s main business is manufacturing and marketing generic drugs, though it is also researching some new drugs. These are initially sold in India and other developing nations; once the original patents expire, they are also imported into the U.S., Europe, and other industrialized nations.

Dr. Reddy’s Laboratories Limited

Type:     Public

Founded:     1984

Headquarters:     Hyderabad

Key people:     Anji Reddy (Chairman)

Industry:     Pharmaceuticals

Revenue:     $502 million (JUL2006)

Employees:     7,525

Website:     www.drreddys.com

Key products-:

Top-15 active pharmaceutical ingredients

* Ciprofloxacin Hydrochloride
* Ramipril
* Terbinafine HCI
* Ibuprofen
* Sertaline Hydrochloride
* Ranitidine HCI Form 2
* Naproxen Sodium
* Naproxen
* Atorvastatin
* Montelukast
* Losartan Potassium
* Sparfloxacin
* Nizatidine
* Ranitidine Hydrochloride Form 1
* Clopidogrel